Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  motexafin gadolinium
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-9 of 9 for your search:
Start Over
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01989, CDR0000737109, NCCTG-N1174, N1174, U10CA180821, U10CA025224, NCT01648348
Ferumoxytol and Gadolinium Magnetic Resonance Imaging (MRI) at 3 Tesla (T) and 7 Tesla (T) in Patients With Malignant Brain Tumors
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: OHSU-2864, 5R01NS053468-02, 2864, SOL-06077-L, NCT00659126
Molecular Imaging With Erlotinib and Bevacizumab
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MIMEB, 2009-012607-26, NCT01047059
Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000728901, ACRIN-6701, CA80098, NCT01562223
Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported
Phase: Phase I
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2014-0616, NCT02390635
Imaging Vascular Properties of Pediatric Brain Tumors Using Ferumoxytol and Gadolinium in a Single Imaging Session
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: OHSU-5405, 3 RO1 CA137488 15S1, SOL-09064-LX, 5405, NCT00978562
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000667125, ACRIN-6690, CA80098, NCT01082224
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-004, NCT01799135
Contrast Enhanced MRI of the Prostate
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1R44CA180425, NCT02245282
Start Over